220 related articles for article (PubMed ID: 20062085)
1. Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma.
Zhu XG; Zhao L; Willingham MC; Cheng SY
Oncogene; 2010 Apr; 29(13):1909-19. PubMed ID: 20062085
[TBL] [Abstract][Full Text] [Related]
2. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
Kato Y; Ying H; Willingham MC; Cheng SY
Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
[TBL] [Abstract][Full Text] [Related]
3. Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis.
Ying H; Suzuki H; Zhao L; Willingham MC; Meltzer P; Cheng SY
Cancer Res; 2003 Sep; 63(17):5274-80. PubMed ID: 14500358
[TBL] [Abstract][Full Text] [Related]
4. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Lu C; Zhao L; Ying H; Willingham MC; Cheng SY
Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453
[TBL] [Abstract][Full Text] [Related]
5. Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma.
Ying H; Suzuki H; Furumoto H; Walker R; Meltzer P; Willingham MC; Cheng SY
Carcinogenesis; 2003 Sep; 24(9):1467-79. PubMed ID: 12869418
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
7. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.
Suzuki H; Willingham MC; Cheng SY
Thyroid; 2002 Nov; 12(11):963-9. PubMed ID: 12490073
[TBL] [Abstract][Full Text] [Related]
8. Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis.
Guigon CJ; Cheng SY
Mol Cell Endocrinol; 2009 Sep; 308(1-2):63-9. PubMed ID: 19549593
[TBL] [Abstract][Full Text] [Related]
9. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
Kim CS; Ying H; Willingham MC; Cheng SY
Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
[TBL] [Abstract][Full Text] [Related]
10. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120
[TBL] [Abstract][Full Text] [Related]
11. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice.
Pringle DR; Vasko VV; Yu L; Manchanda PK; Lee AA; Zhang X; Kirschner JM; Parlow AF; Saji M; Jarjoura D; Ringel MD; La Perle KM; Kirschner LS
J Clin Endocrinol Metab; 2014 May; 99(5):E804-12. PubMed ID: 24512487
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone receptors and cancer.
Kim WG; Cheng SY
Biochim Biophys Acta; 2013 Jul; 1830(7):3928-36. PubMed ID: 22507269
[TBL] [Abstract][Full Text] [Related]
13. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.
Lu C; Zhu X; Willingham MC; Cheng SY
Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131
[TBL] [Abstract][Full Text] [Related]
14. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.
Ying H; Willingham MC; Cheng SY
Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082
[TBL] [Abstract][Full Text] [Related]
15. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
Guigon CJ; Zhao L; Willingham MC; Cheng SY
Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.
Zimonjic DB; Kato Y; Ying H; Popescu NC; Cheng SY
Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579
[TBL] [Abstract][Full Text] [Related]
17. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma.
Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD
Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527
[TBL] [Abstract][Full Text] [Related]
18. Localization and expression of thyroid hormone receptors normal and neoplastic human thyroid.
Crescenzi A; Graziano MF; Carosa E; Papini E; Rucci N; Nardi F; Trimboli P; Calvanese A; Jannini EA; D'Armiento M
J Endocrinol Invest; 2003 Oct; 26(10):1008-12. PubMed ID: 14759075
[TBL] [Abstract][Full Text] [Related]
19. ST6GalNAcII mediates tumor invasion through PI3K/Akt/NF-κB signaling pathway in follicular thyroid carcinoma.
Miao X; Zhao Y
Oncol Rep; 2016 Apr; 35(4):2131-40. PubMed ID: 26820593
[TBL] [Abstract][Full Text] [Related]
20. Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model.
Kim DW; Walker RL; Meltzer PS; Cheng SY
Carcinogenesis; 2013 Oct; 34(10):2389-400. PubMed ID: 23698635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]